Filing identity and reporting period
Important: The supplied filing is for Knight Knox Development Corp., not Artelo Biosciences, Inc. It is a Form 10-K for the fiscal year ended August 31, 2016, filed November 29, 2016. The summary below reflects the filing text provided.
Business context
Knight Knox describes itself as a development-stage company planning an online classified and auction website, offeritnow.com. The site was not fully developed or operational, and the company had no customers, employees, or revenue. It proposed earning advertising revenue and fees of 5% on classified and auction sales. The filing identifies established online marketplaces and classified sites as competitors.
Financial results and liquidity
| Metric | Year ended Aug. 31, 2016 | Year ended Aug. 31, 2015 |
|---|---|---|
| Revenue | $0 | $0 |
| Operating expenses | $29,690 | $15,241 |
| Net loss | $29,690 | $15,241 |
| Cash and current assets | $3,590 | $17,029 |
| Current liabilities | $17,390 | $1,739 |
| Working capital (deficit) | $(13,800) | $15,290 |
| Cash used in operations | $18,489 | $13,502 |
| Cash provided by financing | $5,050 | $15,800 |
2016 expenses consisted of $28,938 in professional fees and $752 in general and administrative costs. Loss per share was reported as $(0.00), basic and diluted. No meaningful operating margin can be calculated because revenue was zero. At August 31, 2016, liabilities included $12,940 in accounts payable and accrued liabilities and a $4,450 non-interest-bearing, on-demand shareholder loan; the company reported no long-term debt. Stockholders’ deficit was $13,800, and accumulated deficit was $60,200.
Changes, subsequent events, and outlook
- Compared with 2015, the net loss increased by $14,449; operating expenses rose from $15,241 to $29,690. Cash fell by $13,439, and working capital shifted from a $15,290 surplus to a $13,800 deficit.
- Management said available cash was insufficient to fund business development and that additional financing would be needed. The auditor issued a going-concern opinion, citing substantial doubt about the company’s ability to continue for the next 12 months without additional capital. Management proposed equity offerings, loans, or funding from management or significant shareholders; no assurance of financing was given.
- After year-end, on November 18, 2016, James Manley resigned from all officer and director roles, and Peter O’Brien was appointed to those roles. O’Brien acquired Manley’s 6,000,000 shares, representing 79% of the 7,640,000 shares outstanding.
- Also on November 18, the company reported that Manley forgave $16,856.31 of company debt and that it entered into a $30,000 senior note payable to Malibu Investments Limited. The note bears 10% interest and matures November 18, 2017; the filing describes possible conversion into a future private placement at a 30% discount, subject to the stated placement terms.
- The filing reports no material commitments or contingencies at year-end, no capital expenditure commitments, and no dividends planned. It also states that disclosure controls and internal control over financial reporting were ineffective, identifying material weaknesses including no audit committee, no independent-director majority, inadequate segregation of duties, and management concentration in one individual.
Most important facts to verify
- Confirm the issuer identity: the provided document names Knight Knox Development Corp., not Artelo Biosciences, Inc.
- Review the audited financial statements and auditor’s report, especially the going-concern qualification and the company’s ability to obtain financing.
- Verify the terms and accounting treatment of the $16,856.31 debt forgiveness and the $30,000 Malibu note, including conversion conditions and any subsequent financing.
- Confirm the website’s development and launch status, funding needs, and whether the proposed revenue model generated any customers or sales.
- Assess the identified internal-control weaknesses and whether governance or control improvements followed the November 2016 management and ownership change.